Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 infection may trigger alopecia areata in some patients.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Histone modification is key in treating chronic inflammatory skin diseases.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Type I interferons play a key role in the development of various skin diseases.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Dengue virus can infect human hair follicle cells and may cause hair loss.

A blood pressure drug, diltiazem, may also help treat influenza.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Mothers have more hair proteins than their children, with age-related differences in protein patterns, and some proteins in hair could indicate early childhood development.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.